Change in fluconazole susceptibility patterns and genetic relationship among oral Candida albicans isolates

AIDS

Volumn 12, Issue 13, 1998, Pages 1601-1610

  Diaz Guerra, Teresa M ^b   Martinez Suarez, Joaquín V ^b   Laguna, Fernando ^b   Valencia, Eulalia ^b   Rodriguez Tudela, Juan L ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b NONE

Author keywords

Antifungal drug resistance; Candida albicans; DNA fingerprinting; Fluconazole; Karyotyping; Oropharyngeal candidosis

Indexed keywords

FLUCONAZOLE; FUNGAL DNA; KETOCONAZOLE;

ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DNA FINGERPRINTING; DNA HYBRIDIZATION; DNA PROBE; DRUG SENSITIVITY; ELECTROPHORESIS; FUNGAL GENETICS; GENETIC HETEROGENEITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KARYOTYPING; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; DNA, FUNGAL; FLUCONAZOLE; HUMANS; KARYOTYPING; MICROBIAL SENSITIVITY TESTS; NUCLEIC ACID HYBRIDIZATION; PROSPECTIVE STUDIES; RECURRENCE; RESTRICTION MAPPING; VARIATION (GENETICS);

EID: 0032504916     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199813000-00006     Document Type: Article

References (24)

1. Rex JH, Rinaldi MG, Pfaller MA: Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995, 39:1-8.
2. Rodríguez-Tudela JL, Martínez-Suárez JV, Dronda F, Laguna F, Chaves F, Valencia E: Correlation of in vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients. J Antimicrob Chemotber 1995, 35:793-804.
3. Barchiesi F, Hollis RJ, McGough DA, Scalise G, Rinaldi MG, Pfaller MA: DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS. Clin Infect Dis 1995, 20:634-640.
4. Pfaller MA, Rhine-Chalberg J, Redding SW, et al.: Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidosis. J Clin Microbiol 1994, 32:59-64.
5. Powderly WG, Robinson K, Keath EJ: Molecular epidemiology of recurrent oral candidosis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. J Infect Dis 1993, 168:463-466.
6. Sangeorzan JA, Bradley SF, He X, et al.: Epidemiology of oral candidosis in HIV-infected patients: colonization, infection, treatment and emergence of fluconazole resistance. Am J Med 1994, 97:339-346.
7. Díaz-Guerra TM, Martínez-Suárez JV, Laguna F, Rodríguez-Tudela JL: Comparison of four molecular typing methods for evaluating genetic diversity among Candida albicans isolates from HIV positive patients with oral candidosis. J Clin Microbiol 1997, 35:856-861.
8. Díaz-Guerra TM, Martínez-Suárez JV, Laguna F, Rodríguez-Tudela JL: Genetic relationship and change in fluconazole susceptibility patterns of multiple Candida albicans strains isolated from HIV-positive patients with recurrent oral candidosis. 13th Congress of the International Society for Human and Animal Mycology. Parma, June 1997 [abstract P122].
9. Barnett JA, Payne RW, Yarrow D: Yeasts: Characteristics and Identification, 2nd Fdn. Cambridge: Cambridge University Press; 1990.
10. Dronda F, Alonso-Sanz A, Laguna F, et al.: Mixed oropharyngeal candidosis due to Candida albicans and non-albicans Candida strains in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1996, 15:446-452.
11. Martins MA, Lozano-Chiu M, Rex JH: Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients. Clin Infect Dis 1997, 25:843-846.
12. National Committee for Clinical Laboratory Standards: Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast. Proposed Standard M27-A. Villanova: National Committee tor Clinical Laboratory Standards; 1997.
13. Martínez-Suárez JV, Rodríguez-Tudela JL: Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain. Antimicrob Agents Chemother 1995, 39:1512-1516.
14. Rodríguez-Tudela JL, Berenguer J, Martínez-Suarez JV, Sánchez R: Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards Reference Macrodilution Method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans. Antimicrob Agents Chemother 1496, 40:1998-2003.
15. Lupetti A, Guzzi C, Paladini A, Swart K, Campa M, Senesi S: Molecular typing of Candida albicans in oral candidosis: karyotype epidemiology with human immunodeficiency virus-seropositive patients in comparison with healthy carriers. J Clin Microbiol 1995, 33:1238-1242.
16. Scherer S, Stevens DA: A C. albicans dispersed, repeated gene family and its epidemiologic applications. Proc Natl Acad Sci USA 1988, 85:1452-1456.
17. Laguna F, Rodríguez-Tudela JL, Martínez-Suárez JV, et al.: Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidosis due to Candida albicans. Clin Infect Dis 1997, 24:124-130.
18. Magee PT, Bowdin L, Staudinger J: Comparison of molecular typing methods for Candida albicans. J Clin Microbiol 1992, 30:2674-2679.
19. Reynes J, Pujol C, Moreau C, et al.: Simultaneous carriage of Candida albicans strains from HIV-infected patients with oral candidosis: multilocus enzyme electrophoresis analysis. FEMS Microbiol Lett 1996, 137:269-273.
20. Anthony RM, Midgley J, Sweet SP, Howell SA: Multiple strains of Candida albicans in the oral cavity of HIV positive patients and HIV negative patients. Microbiol Ecol Health Dis 1995, 8:23-30.
21. Redding SW, Pfaller MA, Messer SA, et al.: Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidosis suffering one or more episodes of infection. J Clin Microbiol 1997, 35:1761-1765.
22. Boerlin P, Boerlin-Petzold F, Goudet J, et al.: Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting. J Clin Microbiol 1996, 34:1235-1248.
23. Lockhart SR, Fritch JJ, Studervant Meier A, et al.: Colonizing populations are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and C1 sequencing. J Clin Microbiol 1995, 33:1501-1509.
24. Rodríguez-Tudela JL, Martínez-Suárez JV, Dronda F, et al.: Correlation of in-vitro susceptibility results with clinical response: a study of azole therapy in AIDS patients. J Antimicrob Chemother 1995, 35:793-804.